On June 28, Keji Pharmaceutical -B (02171.HK) spent HKD 720,000 to repurchase 150,000 shares.

On June 28th, Keji Pharmaceutical -B (02171.HK) announced that it had spent HKD 720,000 to repurchase 150,000 shares.

Gelonghui FinanceJun 28 07:36 ET

CARsgen Therapeutics' Substantial Shareholder Boosts Stake to 37.78%

YIJIE Biotech Holding and parties acting in concert with it bought an aggregate of 1.9 million shares of CARsgen Therapeutics Holdings (HKG:2171) in the secondary market this year, according to a Thur

MT NewswiresJun 27 04:36 ET

Kangji Pharmaceutical (02171) under Hong Kong Stock Connect: the major shareholder has increased shareholding by 1.9 million shares, and the company has repurchased 3.98 million shares.

Jingu Finance News | Koji Pharmaceutical (02171) announced that the board of directors was informed by Yijie Biology that the Yijie concerted action group has purchased a total of 1.9035 million shares of the company's stock within this year until June 25, 2024 (after the close of trading), accounting for approximately 0.33% of the total issued shares. After increasing its shareholding, the Yijie concerted action group holds 217 million shares of the company's stock, accounting for approximately 37.78% of the total issued shares. In addition, as of the close of trading on June 25, 2024, the company has repurchased a total of 3.9855 million shares of its own stock, accounting for approximately 0.69% of the total issued shares. The funds used to repurchase the shares are from...

金吾財訊Jun 26 21:09 ET

Keji Pharmaceutical-B (02171.HK): Yijie Joint Action Group has purchased a total of 1.9035 million shares.

On June 27th, Keji Pharmaceutical-B (02171.HK) announced that the board of directors had been informed by the company's major shareholder, Yijie Biotechnology Holdings Limited ("Yijie Biotechnology"), that Yijie Biotechnology and its concerted action parties ( collectively referred to as the "Yijie concerted action group") plan to acquire the company's shares on the public market within about twelve months from the date of the announcement. The board of directors was recently informed by Yijie Biotechnology that the Yijie concerted action group has purchased a total of 1.9035 million shares, accounting for approximately 0.33% of the total issued shares from the beginning of this year to the close of June 25th, 2024. After increasing the shareholding, Yijie.

Gelonghui FinanceJun 26 20:04 ET

Express News | CARsgen Therapeutics - After Shareholding Increase, Yijie Concert Group Holds 37.78% of Total Issued Shares of Co

ReutersJun 26 20:02 ET

Express News | CARsgen Therapeutics - Informed by Yijie Biotech That Yijie Concert Purchased 0.33% of Total Issued Shares of Co Within This Year up to June 25

ReutersJun 26 20:01 ET